[Various clinical and experimental problems in the therapy of urinary tract infections].
D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use*; D002509:Cephaloridine / Q000627:therapeutic use; D003091:Colistin / Q000627:therapeutic use; D005839:Gentamicins / Q000627:therapeutic use; D005921:Glomerulonephritis / Q000188:drug therapy; D006801:Humans; D009268:Nalidixic Acid / Q000627:therapeutic use; D009582:Nitrofurantoin / Q000627:therapeutic use; D011704:Pyelonephritis / Q000188:drug therapy; D013411:Sulfadiazine / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000892:Anti-Infective Agents, Urinary; D005839:Gentamicins; D013411:Sulfadiazine; D009268:Nalidixic Acid; D009582:Nitrofurantoin; D002509:Cephaloridine; D003091:Colistin
Nĕkteré klinické a experimentalní otázky terapie infekcí mocových cest.